Top of page
Lawyers

Jennifer (Yujia) Jiang

Lawyers
Associate in our Corporate practice, currently practicing as a Registered Foreign Lawyer in Hong Kong.
Languages
Mandarin
Languages
Mandarin

Experience highlights

  • Black Spade Acquisition Co.'s $150 million U.S. IPO on the NYSE
  • Baidu's $3.1 billion Hong Kong secondary listing
  • Antengene's $357 million Hong Kong IPO and global offering
  • RemeGen's $514.3 million Hong Kong IPO and global offering
  • InnoCare Pharma's $287 million Hong Kong IPO and global offering
  • LIZHI INC's $45.1 million SEC-registered IPO on Nasdaq
  • DouYu's $775 million SEC-registered U.S. IPO on Nasdaq
  • CStone Pharmaceuticals' $285 million Hong Kong IPO and global offering
  • CNFinance's $51.94 million SEC-registered U.S. IPO on the NYSE
  • DuPont Fabros Technology, Inc. $200 million SEC-registered at-the-market offering
  • Johnson Controls International plc $500 million senior notes offering
View all experience
Education
J.D., Northwestern University Pritzker School of Law
LL.M., Cornell Law School
LL.B., Civil, Commercial and Economic Law School, China University of Political Science and Law
Professional history
  • Davis Polk since 2014
Back to top